Literature DB >> 33427947

Radiology in the lead: towards radiological profiling for precision medicine in glioblastoma patients? Editorial comment on Glioblastoma patients with a moderate vascular profile benefit the most from MGMT methylation.

Bart Roelf Jan van Dijken1, A van der Hoorn2.   

Abstract

Entities:  

Year:  2021        PMID: 33427947     DOI: 10.1007/s00330-020-07588-w

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


× No keyword cloud information.
  1 in total

1.  MGMT methylation may benefit overall survival in patients with moderately vascularized glioblastomas.

Authors:  Elies Fuster-Garcia; David Lorente Estellés; María Del Mar Álvarez-Torres; Javier Juan-Albarracín; Eduard Chelebian; Alex Rovira; Cristina Auger Acosta; Jose Pineda; Laura Oleaga; Enrique Mollá-Olmos; Silvano Filice; Paulina Due-Tønnessen; Torstein R Meling; Kyrre E Emblem; Juan M García-Gómez
Journal:  Eur Radiol       Date:  2020-10-01       Impact factor: 5.315

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.